Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$152.50
-0.4%
$155.67
$140.68
$169.99
$366.93B0.427.98 million shs7.53 million shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$260.50
-0.2%
$242.84
$190.88
$280.25
$723.95B1.079.58 million shs6.51 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$23.49
-2.1%
$23.22
$17.67
$25.17
$45.06B1.0216.43 million shs13.28 million shs
Prologis, Inc. stock logo
PLD
Prologis
$104.99
+0.3%
$104.62
$85.35
$132.57
$97.42B1.254.19 million shs3.49 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.27%+4.63%-2.44%-4.04%+1.27%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
-1.68%-1.77%+14.04%-2.14%+30.82%
Kenvue Inc. stock logo
KVUE
Kenvue
-0.64%+3.16%+7.65%+7.24%+20.16%
Prologis, Inc. stock logo
PLD
Prologis
-3.69%-2.52%+6.12%-13.38%-5.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9538 of 5 stars
3.35.04.23.93.42.51.9
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.5282 of 5 stars
2.33.04.22.02.03.32.5
Kenvue Inc. stock logo
KVUE
Kenvue
2.3894 of 5 stars
2.23.01.70.03.01.71.3
Prologis, Inc. stock logo
PLD
Prologis
4.5304 of 5 stars
3.33.04.22.22.91.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.8812.05% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.57
Moderate Buy$266.202.19% Upside
Kenvue Inc. stock logo
KVUE
Kenvue
2.42
Hold$25.337.87% Upside
Prologis, Inc. stock logo
PLD
Prologis
2.65
Moderate Buy$120.4214.70% Upside

Current Analyst Ratings Breakdown

Latest JPM, PLD, JNJ, and KVUE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$305.00 ➝ $315.00
5/20/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$260.00 ➝ $295.00
5/20/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$255.00 ➝ $285.00
5/20/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$220.00 ➝ $235.00
5/20/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$235.00 ➝ $236.00
5/19/2025
Prologis, Inc. stock logo
PLD
Prologis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$146.00 ➝ $119.00
5/15/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$305.00
5/14/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$169.00 ➝ $153.00
5/12/2025
Kenvue Inc. stock logo
KVUE
Kenvue
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $23.00
(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$89.33B4.11$12.53 per share12.17$29.69 per share5.14
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$172.86B4.19$21.49 per share12.12$116.13 per share2.24
Kenvue Inc. stock logo
KVUE
Kenvue
$15.30B2.94$1.65 per share14.24$5.85 per share4.01
Prologis, Inc. stock logo
PLD
Prologis
$8.38B11.62$5.39 per share19.49$63.17 per share1.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9922.9313.782.5618.20%34.24%13.63%7/16/2025 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$58.47B$20.3713.2013.412.8320.96%16.99%1.31%7/11/2025 (Estimated)
Kenvue Inc. stock logo
KVUE
Kenvue
$1.03B$0.5544.3118.942.626.66%20.97%8.17%8/5/2025 (Estimated)
Prologis, Inc. stock logo
PLD
Prologis
$3.64B$4.0026.2516.932.7045.50%6.44%3.95%7/16/2025 (Estimated)

Latest JPM, PLD, JNJ, and KVUE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Kenvue Inc. stock logo
KVUE
Kenvue
$0.23$0.24+$0.01$0.17$3.69 billion$3.74 billion
4/16/2025Q1 2025
Prologis, Inc. stock logo
PLD
Prologis
$1.38$1.42+$0.04$1.42$1.99 billion$1.99 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
4/11/2025Q1 2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.63$5.07+$0.44$5.07$43.62 billion$45.30 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.41%+5.43%57.84%64 Years
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$5.602.15%+8.10%27.49%15 Years
Kenvue Inc. stock logo
KVUE
Kenvue
$0.823.49%N/A149.09%1 Years
Prologis, Inc. stock logo
PLD
Prologis
$4.043.85%+15.07%101.00%12 Years

Latest JPM, PLD, JNJ, and KVUE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/19/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.402.12%7/3/20257/3/20257/31/2025
5/8/2025
Prologis, Inc. stock logo
PLD
Prologis
quarterly$1.013.83%6/17/20256/17/20256/30/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
4/16/2025
Kenvue Inc. stock logo
KVUE
Kenvue
quarterly$0.20503.57%5/14/20255/14/20255/28/2025
3/18/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.402.38%4/4/20254/4/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.24
0.88
0.89
Kenvue Inc. stock logo
KVUE
Kenvue
0.66
1.00
0.69
Prologis, Inc. stock logo
PLD
Prologis
0.53
0.75
0.43

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
71.55%
Kenvue Inc. stock logo
KVUE
Kenvue
97.64%
Prologis, Inc. stock logo
PLD
Prologis
93.50%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
0.47%
Kenvue Inc. stock logo
KVUE
Kenvue
1.68%
Prologis, Inc. stock logo
PLD
Prologis
0.57%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
293,7002.78 billion2.77 billionOptionable
Kenvue Inc. stock logo
KVUE
Kenvue
22,0001.92 billion1.91 billionOptionable
Prologis, Inc. stock logo
PLD
Prologis
2,470927.93 million922.23 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$152.50 -0.68 (-0.44%)
Closing price 03:59 PM Eastern
Extended Trading
$153.11 +0.61 (+0.40%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

JPMorgan Chase & Co. stock logo

JPMorgan Chase & Co. NYSE:JPM

$260.50 -0.54 (-0.21%)
Closing price 03:59 PM Eastern
Extended Trading
$260.88 +0.38 (+0.14%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

Kenvue stock logo

Kenvue NYSE:KVUE

$23.48 -0.52 (-2.15%)
Closing price 03:59 PM Eastern
Extended Trading
$23.55 +0.07 (+0.28%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Prologis stock logo

Prologis NYSE:PLD

$104.99 +0.32 (+0.31%)
Closing price 03:59 PM Eastern
Extended Trading
$105.64 +0.66 (+0.62%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment.